Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Insurance Coverage for Opioid Lawsuits & Investigations

January 17, 2018, Covington Alert

Dozens of pharmaceutical manufacturers, wholesale distributors, and retailers have been named as defendants in opioid-related lawsuits, investigations, and congressional inquiries across the country. These actions and investigations include allegations that defendants misleadingly marketed opioids, failed to comply with regulatory requirements to report suspicious orders of opioids, and improperly filled fraudulent prescriptions for opioids. Some of these companies and their directors and officers are also targets of securities class action and shareholder derivative lawsuits related to the companies’ marketing, sale, distribution, and dispensing of opioid painkillers. Defendants are disputing these allegations and mounting a vigorous defense.

Share this article: